Oral methylated N-aryl chitosan derivatives for inducing immune responses to ovalbumin

Tropical Journal of Pharmaceutical Research

Volumn 11, Issue 6, 2012, Pages 899-908

  Suksamran, Tittaya ^a   Kowapradit, Jariya ^a   Ngawhirunpat, Tanasait ^a   Rojanarata, Theerasak ^a   Sajomsang, Warayuth ^b   Pitaksuteepong, Tasana ^c   Opanasopit, Praneet ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c NARESUAN UNIVERSITY   (Thailand)

Author keywords

Absorption enhancement; Chitosan derivatives; Immunoadjuvants; Oral vaccine delivery; Ovalbumin

Indexed keywords

CHITOSAN DERIVATIVE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; METHYLATED N (4 N,N DIMETHYLAMINOBENZYL)CHITOSAN; METHYLATED N (4 N,N DIMETHYLAMINOCINNAMYL)CHITOSAN; METHYLATED N (4 PYRIDINYLMETHYL)CHITOSAN; OVALBUMIN; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRIC RESISTANCE; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; PH;

EID: 84871746507     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v11i6.5     Document Type: Article

References (22)

1. Arca HC, Gunbeyaz M, Senel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 2009; 8(7): 937-953.
2. Lubben I, Verhoef JC, Borchard G, Junginger HE. Chitosan for mucosal vaccination. Adv Drug Deliv Rev 2001; 52: 139-144.
3. Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 2001; 19(6): 661-668.
4. Villiers C, Chevallet M, Diemer H, Couderc R, Freitas H, Van Dorsselaer A, Marche PN, Rabilloud T. From secretome analysis to immunology: chitosan induces major alterations in the activation of dendritic cells via a TLR4-dependent mechanism. Mol Cell Proteomics 2009; 8(6): 1252-1264.
5. Sajomsang W, Rungsardthong Ruktanonchai U, Gonil P, Nuchuchua O. Mucoadhesive property and biocompatibility of methylated Naryl chitosan derivatives. Carbohyd Polym 2009; 78: 945-952.
6. Kowapradit J, Opanasopit P, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W. Methylated N-(4-N, N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2). AAPS PharmSciTech 2008; 9: 1143-1152.
7. Kowapradit J, Opanasopit P, Ngawhiranpat T, Rojanarata T, Ruktanonchai U, Sajomsang W. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells. Drug Deliv 2010; 17: 301-312.
8. Kowapradit J, Opanasopit P, Ngawhiranpat T, Rojanarata T, Sajomsang W. Structure- activity relationships of methylated N-aryl chitosan derivatives for enhancing paracellular permeability across Caco-2 cells. Carbohyd Polym 2011; 83: 430-437.
9. Sajomsang W, Gonil P, Saesoo S. Synthesis and antibacterial activity of methylated N-(4-N,Ndimethylaminocinnamyl) chitosan chloride. Eur Polym J 2009; 45: 2319-2328.
10. Sajomsang W, Tantayanon S, Tangpasuthadol V, Daly WH. Synthesis of methylated chitosan containing aromatic moieties: Chemoselectivity and effect on molecular weight. Carbohyd Polym 2008; 72: 740-750.
11. Chae Y, Jang MK, Nah JW. Influence of molecularweight on oral absorption of water soluble chitosans. J Control Release 2005; 102: 383-394.
12. Pitaksuteepong T. Potential of medium-chain glycerides-based microemulsions for provoking immune response following oral administration. Naresuan University J 2003; 11: 49-59.
13. Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994; 11: 1358-1361.
14. Schipper NGM, Olsson S, Hoogstraate JA, Boer AGD, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs II: Mechanism of absorption enhancement. Pharm Res 1997; 14: 923-929.
15. Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. J Control Release 2007; 121: 168-175.
16. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005; 57: 1556-1568.
17. Kowapradit J, Rojanarata T, Ngawhirunpat T, Apirakaramwong A, Sajomsang W, Opanasopit P. Application of methylated N-(4- N,N-Dimethylaminocinnamyl) chitosan for oral protein drug delivery. Adv Mater Res 2012. (inpress).
18. Boontha S, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T. Chitosan and trimethyl chitosan particles as oral vaccine delivery systems: comparison of the potential to initiate immune responses. J Met Mater Miner 2011; 21: 43-47.
19. De Magistris MT. Mucosal delivery of vaccine antigens and its advantages in pediatrics Adv Drug Deliv Rev 2006; 58: 52-67.
20. Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containingadjuvant formulations. Vaccine 2000; 19: 661-668.
21. Bivas-Benita M, Laloup M, Versteyhe S, Dewit J, De Braekeleer J, Jongert E, Borchard G. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharm 2003; 266: 17-27.
22. Xie Y, Zhou NJ, Gong YF, Zhou XJ, Chen J, Hu SJ, Lu NH, Hou XH. Thimmune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World J Gastroenterol 2007; 13: 1547-1553.